Literature DB >> 28972462

Folate-conjugated liposomes target and deliver therapeutics to immune cells in a rat model of rheumatoid arthritis.

Scott Poh1, Venkatesh Chelvam2, Lindsay E Kelderhouse3, Wilfredo Ayala-López4, Balasubramanian Vaitilingam3, Karson S Putt5, Philip S Low3,5.   

Abstract

AIM: We endeavored to create a folate-targeted liposome (Fol-liposome) that could selectively target areas of inflammation. MATERIALS &
METHODS: Fol-liposomes were prepared with encapsulated DiD fluorophore or betamethasone (BM) to image and treat an adjuvant-induced rat model of rheumatoid arthritis.
RESULTS: Fol-liposomes selectively accumulated in arthritic rat paws to a greater extent than nontargeted liposomes. When these Fol-liposomes were used to encapsulate BM and administered to arthritic rats, animals exhibited less paw swelling, lower arthritis scores, a reduction in bone erosion, less splenomegaly and better maintenance of body weight when compared with nontreated or nontargeted BM-containing liposome groups.
CONCLUSION: Fol-liposomes can selectively deliver imaging and therapeutic agents to sites of inflammation in a rat model of rheumatoid arthritis.

Entities:  

Keywords:  activated macrophages; arthritis; folate liposome; folate receptor; folate targeting; inflammatory disease; liposome

Mesh:

Substances:

Year:  2017        PMID: 28972462     DOI: 10.2217/nnm-2017-0166

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  7 in total

1.  Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Bodhraj Acharya; Kamal D Moudgil
Journal:  Nanomedicine (Lond)       Date:  2019-04-02       Impact factor: 5.307

2.  Peptide-directed liposomal delivery improves the therapeutic index of an immunomodulatory cytokine in controlling autoimmune arthritis.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  J Control Release       Date:  2018-08-04       Impact factor: 9.776

3.  Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritis.

Authors:  Yingwen Hu; Bingbing Wang; Jiayin Shen; Stewart A Low; Karson S Putt; Hans W M Niessen; Eric L Matteson; Linda Murphy; Clemens Ruppert; Gerrit Jansen; Stephen J Oliver; Yang Feng; Dimiter S Dimitrov; Cheryl Nickerson-Nutter; Philip S Low
Journal:  Arthritis Res Ther       Date:  2019-06-07       Impact factor: 5.156

4.  Hybrid micelles containing methotrexate-conjugated polymer and co-loaded with microRNA-124 for rheumatoid arthritis therapy.

Authors:  Fei Hao; Robert J Lee; Lihuang Zhong; Shiyan Dong; Chunmiao Yang; Lirong Teng; Qingfan Meng; Jiahui Lu; Jing Xie; Lesheng Teng
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

Review 5.  Instructive cartilage regeneration modalities with advanced therapeutic implantations under abnormal conditions.

Authors:  Zhonghan Wang; Hanxiang Le; Yanbing Wang; He Liu; Zuhao Li; Xiaoyu Yang; Chenyu Wang; Jianxun Ding; Xuesi Chen
Journal:  Bioact Mater       Date:  2021-11-18

Review 6.  Immunologically Inert Nanostructures as Selective Therapeutic Tools in Inflammatory Diseases.

Authors:  Laura Talamini; Eiji Matsuura; Luisa De Cola; Sylviane Muller
Journal:  Cells       Date:  2021-03-23       Impact factor: 6.600

Review 7.  Liposomal Nanosystems in Rheumatoid Arthritis.

Authors:  Margarida Ferreira-Silva; Catarina Faria-Silva; Pedro Viana Baptista; Eduarda Fernandes; Alexandra Ramos Fernandes; Maria Luísa Corvo
Journal:  Pharmaceutics       Date:  2021-03-27       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.